Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Trading Statement

13 Feb 2008 09:40

Imaginatik PLC13 February 2008 13 February 2008 Imaginatik plc ("Imaginatik" or the "Company") Trading Update Imaginatik plc (AIM: IMTK), a leading provider of collaborative innovation andproblem-solving software and processes announces today that an improved tradingperformance in the second half of the year should result in a profit for thisperiod. This outcome is expected to strengthen the balance sheet and provide apositive operating cash flow for the second half year. The Company's recurringrevenue base continues to build well and will help underpin our operations intothe next financial year. In view of the weak trading experienced in the first half of the financial yearand not withstanding the much improved performance in the second half year, theCompany is unlikely to reach the market forecast of £4.4m of revenue for theyear to 31 March 2008. Overheads continue to be tightly contained. As a resultthe level of business required to reach break-even for the full year has beensignificantly reduced. Imaginatik also announces today that it is in final negotiations with a majorcustomer which may or may not lead to it becoming a strategic investor in theCompany. The Board will provide additional information to the market as soon asthe agreement is concluded. Mark Turrell, CEO of Imaginatik plc, commented, "I am pleased to see theCompany's performance improving after a difficult first nine months as a publiccompany. We now have a great deal of momentum within the business, our pipelineis strong and our recent presence at the World Economic Forum in Davos will helpaccelerate the current level of activity. We believe having a significantstrategic investor on board would be extremely positive for Imaginatik and itsshareholders and we will provide further information in due course." For further information please contact: Imaginatik plc Tel: +44 (0)20 7917 2975Mark Turrell, CEO / Shawn Taylor, CFO WH Ireland Tel: +44 (0)121 265 6330Tim Cofman/Katy Birkin Investor relations and UK mediaICIS Tel: +44 (0)20 7651 8688Tom Moriarty / Caroline Evans Jones About Imaginatik Imaginatik is the leading provider of Collaborative Innovation and ProblemSolving software and process to the world's leading companies. More than 100clients, including Hewlett-Packard, IBM and Pfizer, rely on Imaginatik'ssoftware, consulting and research to enable their best-of-breed innovationactivities. Imaginatik's software and consulting services have helped clients discoversignificant sources of additional revenue, as well as tangible cost savings,process improvements and increased product pipeline. Imaginatik is alsocommitted to developing strategic solutions in the field of innovation, workingwith academic institutions such as the London Business School and the CassSchool of Business, London, as well as leading practitioners of corporateinnovation. For further information please visit www.imaginatik.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Jun 20107:00 amRNSAppointment of Chief Operating Officer
1st Jun 20103:48 pmRNSHolding(s) in Company
13th May 20107:00 amRNSAppointment of Interim Vice President of Sales
6th May 20102:11 pmRNSHolding(s) in Company
28th Apr 20107:00 amRNSTrading Update
10th Mar 20107:00 amRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNSTrading Update
22nd Feb 20107:00 amRNSWindsor Foods Selects Imaginatik
17th Feb 20109:45 amRNSDirector Shareholding
29th Jan 201011:41 amRNSContract Win
22nd Dec 20097:00 amRNSDirectorate Change
17th Dec 20097:00 amRNSContract Win with Global Consumer Products Company
11th Dec 20097:00 amRNSContract Extension
17th Nov 20097:00 amRNSInterim Results
13th Nov 20097:00 amRNSContract Win
12th Nov 20097:00 amRNSNotice of Results
9th Oct 20097:00 amRNSTrading Update & Directorate Change
2nd Oct 20097:00 amRNSContract Win with global technology business
28th Sep 20097:00 amRNSContract Win with US Insurer
24th Sep 20097:00 amRNSDirector/PDMR Shareholding
23rd Sep 20097:00 amRNSProduct Launch
10th Sep 20097:00 amRNSContract Win
8th Sep 20097:00 amRNSWorld Economic Forum
13th Aug 20094:26 pmRNSHolding(s) in Company
13th Aug 20093:00 pmRNSHolding(s) in Company
13th Aug 200911:18 amRNSDirector/PDMR Shareholding
12th Aug 20095:17 pmRNSAdditional Listing
10th Aug 20097:00 amRNSPlacing
28th Jul 20097:00 amRNSAGM Statement
3rd Jul 20092:21 pmRNSDirector/PDMR - Share Subscription
29th Jun 20092:34 pmRNSAnnual Report & Accounts
17th Jun 20097:00 amRNSFinal Results
2nd Jun 20097:00 amRNSChange of Adviser & Notice of Results
15th May 200910:33 amRNSDirectorate Change
3rd Apr 20097:00 amRNSContract Win & Trading Update
19th Mar 20097:00 amRNSContract Extension with Chubb
5th Feb 20097:00 amRNSManagement Appointment
23rd Jan 20094:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20097:00 amRNSWorld Economic Forum
15th Jan 20097:00 amRNSTrading on PLUS
14th Jan 20093:10 pmRNSDirector/PDMR Shareholding
14th Jan 20097:00 amRNSPharmaceutical Contract Win
9th Jan 20099:09 amRNSDirector/PDMR Shareholding
7th Jan 20091:35 pmRNSDirector/PDMR Shareholding
5th Jan 200911:10 amRNSDirector/PDMR Shareholding
5th Jan 20099:40 amRNSDirector/PDMR Shareholding
2nd Jan 20099:05 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSTotal Voting Rights
24th Dec 200810:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.